Research School of Chemistry , The Australian National University , Acton , ACT 2601 , Australia.
Illawarra Health and Medical Research Institute and School of Biological Sciences , University of Wollongong , Wollongong , NSW 2522 , Australia.
Acc Chem Res. 2018 Mar 20;51(3):745-752. doi: 10.1021/acs.accounts.7b00250. Epub 2018 Feb 14.
Molecular chaperone proteins perform a diversity of roles inside and outside the cell. One of the most important is the stabilization of misfolding proteins to prevent their aggregation, a process that is potentially detrimental to cell viability. Diseases such as Alzheimer's, Parkinson's, and cataract are characterized by the accumulation of protein aggregates. In vivo, many proteins are metastable and therefore under mild destabilizing conditions have an inherent tendency to misfold, aggregate, and hence lose functionality. As a result, protein levels are tightly regulated inside and outside the cell. Protein homeostasis, or proteostasis, describes the network of biological pathways that ensures the proteome remains folded and functional. Proteostasis is a major factor in maintaining cell, tissue, and organismal viability. We have extensively investigated the structure and function of intra- and extracellular molecular chaperones that operate in an ATP-independent manner to stabilize proteins and prevent their misfolding and subsequent aggregation into amorphous particles or highly ordered amyloid fibrils. These types of chaperones are therefore crucial in maintaining proteostasis under normal and stress (e.g., elevated temperature) conditions. Despite their lack of sequence similarity, they exhibit many common features, i.e., extensive structural disorder, dynamism, malleability, heterogeneity, oligomerization, and similar mechanisms of chaperone action. In this Account, we concentrate on the chaperone roles of α-crystallins and caseins, the predominant proteins in the eye lens and milk, respectively. Intracellularly, the principal ATP-independent chaperones are the small heat-shock proteins (sHsps). In vivo, sHsps are the first line of defense in preventing intracellular protein aggregation. The lens proteins αA- and αB-crystallin are sHsps. They play a crucial role in maintaining solubility of the crystallins (including themselves) with age and hence in lens proteostasis and, ultimately, lens transparency. As there is little metabolic activity and no protein turnover in the lens, crystallins are very long lived proteins. Lens proteostasis is therefore very different to that in normal, metabolically active cells. Crystallins undergo extensive post-translational modification (PTM), including deamidation, racemization, phosphorylation, and truncation, which can alter their stability. Despite this, the lens remains transparent for tens of years, implying that lens proteostasis is intimately integrated with crystallin PTMs. Many PTMs do not significantly alter crystallin stability, solubility, and functionality, which thereby facilitates lens transparency. In the long term, however, extensive accumulation of crystallin PTMs leads to large-scale crystallin aggregation, lens opacification, and cataract formation. Extracellularly, various ATP-independent molecular chaperones exist that exhibit sHsp-like structural and functional features. For example, caseins, the major milk proteins, exhibit chaperone ability by inhibiting the amorphous and amyloid fibrillar aggregation of a diversity of destabilized proteins. Caseins maintain proteostasis within milk by preventing deleterious casein amyloid fibril formation via incorporation of thousands of individual caseins into an amorphous structure known as the casein micelle. Hundreds of nanoclusters of calcium phosphate are sequestered within each casein micelle through interactions with short, highly phosphorylated casein sequences. This results in a stable biofluid that contains a high concentration of potentially amyloidogenic caseins and concentrations of calcium and phosphate that can be far in excess of the solubility of calcium phosphate. Casein micelle formation therefore performs vital roles in neonatal nutrition and calcium homeostasis in the mammary gland.
分子伴侣蛋白在细胞内外执行多种功能。其中最重要的作用之一是稳定错误折叠的蛋白质,防止它们聚集,因为蛋白质聚集对细胞活力可能是有害的。阿尔茨海默病、帕金森病和白内障等疾病的特征是蛋白质聚集物的积累。在体内,许多蛋白质是亚稳定的,因此在轻度去稳定条件下,它们具有固有错误折叠、聚集和失去功能的倾向。因此,蛋白质水平在细胞内外受到严格调节。蛋白质动态平衡或蛋白质稳态描述了确保蛋白质组保持折叠和功能的生物途径网络。蛋白质稳态是维持细胞、组织和生物体活力的主要因素。我们已经广泛研究了在不需要 ATP 的情况下起作用的细胞内和细胞外分子伴侣的结构和功能,以稳定蛋白质并防止它们错误折叠和随后聚集为无定形颗粒或高度有序的淀粉样纤维。这些类型的伴侣蛋白在维持正常和应激(例如,升高的温度)条件下的蛋白质稳态方面非常重要。尽管它们缺乏序列相似性,但它们表现出许多共同的特征,即广泛的结构无序性、动态性、可塑性、异质性、寡聚化和类似的伴侣蛋白作用机制。在本综述中,我们集中讨论了 α-晶状体蛋白和酪蛋白这两种主要的眼部晶状体和牛奶蛋白的伴侣蛋白作用。在细胞内,主要的 ATP 非依赖性伴侣蛋白是小分子热休克蛋白(sHsps)。在体内,sHsps 是防止细胞内蛋白质聚集的第一道防线。晶状体蛋白 αA-和 αB-晶状体蛋白是 sHsps。它们在维持晶状体蛋白(包括自身)随年龄增长的可溶性方面发挥着至关重要的作用,因此在晶状体蛋白质稳态中,最终在晶状体透明度方面发挥着至关重要的作用。由于晶状体中几乎没有代谢活性和蛋白质周转,晶状体蛋白是非常长寿的蛋白质。因此,晶状体蛋白质稳态与正常、代谢活跃的细胞中的蛋白质稳态非常不同。晶状体蛋白经历广泛的翻译后修饰(PTM),包括脱酰胺、消旋、磷酸化和截断,这可能会改变它们的稳定性。尽管如此,晶状体仍然保持透明数十年,这意味着晶状体蛋白质稳态与晶状体蛋白 PTM 密切相关。许多 PTM 不会显著改变晶状体蛋白的稳定性、可溶性和功能,从而促进晶状体的透明度。然而,从长远来看,晶状体蛋白 PTM 的大量积累会导致晶状体蛋白的大规模聚集、晶状体混浊和白内障形成。细胞外存在各种具有 sHsp 样结构和功能特征的 ATP 非依赖性分子伴侣。例如,牛奶中的主要蛋白质酪蛋白通过抑制多种不稳定蛋白质的无定形和淀粉样纤维聚集,表现出伴侣蛋白的能力。酪蛋白通过将数千个酪蛋白单体纳入称为酪蛋白胶束的无定形结构,来维持牛奶中的蛋白质动态平衡。数百个纳米级的磷酸钙纳米簇通过与短的、高度磷酸化的酪蛋白序列相互作用被隔离在每个酪蛋白胶束中。这导致了一种稳定的生物流体,其中含有高浓度的潜在淀粉样蛋白酪蛋白和钙和磷酸盐的浓度可以远远超过磷酸钙的溶解度。因此,酪蛋白胶束的形成在新生儿营养和乳腺中的钙动态平衡中发挥着重要作用。